Impact of gender on the accuracy of dobutamine stress echocardiography for diagnosis of coronary artery disease;Influencia del sexo en el rendimiento de la ecocardiografía con dobutamina para el diagnóstico de la cardiopatía isquémica

Revista Espanola de Cardiologia

Volumn 52, Issue 12, 1999, Pages 1060-1065

  Rollan, María Jesús ^b   San Román, José Alberto ^b   Vilacosta, Isidre ^b   Ortega, José Ramón ^a   Serrador, Ana ^b   Pastor, Gemma ^b   Medina, Alfonso ^a   Bratos, José Luis ^b   Fernández Avilés, Francisco ^b  

^a Hospital Nuestra Senora del Pino   (Spain)

^b NONE

Author keywords

Coronary disease; Echocardiography; Stress; Women

Indexed keywords

ATROPINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT; DOBUTAMINE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; STATISTICS;

AGED; ATROPINE; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS;

EID: 0041404435     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Alonso I, Regidor E, Rodríguez C, Gutiérrez-Fisac JL. Principales causas de muerte en España, 1992. Med Clin (Barc) 1996; 107: 441-445.
2. Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F et al. Correlations among history of angina, ST-segment response and prevalence of coronary artery disease in the coronary artery surgery study (CASS). N Engl J Med 1979; 301: 230-235.
3. Barolsky SM, Gilbert CA, Faruqui A, Nutter DO, Schlant RC. Differences in electrocardiographic response to exercise of women and men: a non-bayesian factor. Circulation 1979; 60: 1.021-1.027.
4. Douglas PS. Coronary artery disease in women. En: Braunwald E, editor. Heart disease, textbook of cardiovascular medicine. Filadelfia: W.B. Saunders Company, 1997; 1.704-1.714.
5. Holdright DR, Fox KM. Characterization and identification of women with angina pectoris. Eur Heart J 1996; 17: 510-517.
6. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WFC, Froelicher VF et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee on exercise testing). J Am Coll Cardiol 1997; 30: 260-315.
7. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy ot Tl-201 and Tc-99 sestamibi SPECT imaging (perfusion and ECG-gated SPECT) indetecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69-77.
8. Kiat H, Maddahi J, Roy LT, Train KV, Friedman J, Resser K et al. Comparison of technetium 99m methoxy isonitrile and thalium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1-11.
9. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995; 26: 335-341.
10. Masini M, Picano E, Lattanzi F, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in women: correlation with exercise electrocardiography test and coronary arteriography. J Am Coll Cardiol 1988; 12: 682-685.
11. Peral V, Vilacosta I, San Román JA, Castillo JA, Batlle E, Hernández M et al. Prueba no invasiva de elección para el diagnóstico de enfermedad coronaria en mujeres. Rev Esp Cardiol 1997; 50: 421-427.
12. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1.605-1.614.
13. San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Peral V, Sánchez-Harguindey L et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 1996; 110: 1.248-1.254.
14. Krahwinkel W, Ketteler T, Gödke J, Wolfertz J, Ulbricht LJ, Krakau I et al. Dobutamine stress echocardiography. Eur Heart J 1997; 18 (Supl D): D9-D15.
15. Marwick T, D'Hondt AM, Baudhuin T, Willermart B, Wijns W, Detry JM et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22: 159-167.
16. Bach DS, Muller DWM, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 1994; 24: 928-933.
17. Schiller N, Sha PM, Crawford M. Recomendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-368.
18. San Román JA, Rollán MJ, Vilacosta I, Castillo JA, Meroño E, Hernández M et al. Ecocardiografía y gammagrafiacute;a con MIBI-SPECT durante la infusión de dobutamina en el diagnóstico de la enfermedad coronaria. Rev Esp Cardiol 1995; 48: 606-614.
19. Castillo JA, Vilacosta I, San Román JA. Rollán MJ, Peral V, De la Torre MM, Sánchez-Harguindey L. Ecocardiografía con dobutamina en pacientes hipertensos con dolor torácico. Rev Esp Cardiol 1996; 49: 747-752.
20. Levy H, Boas EP. Coronary artery disease in women. JAMA 1936; 107: 97-102.
21. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993; 88: 2.548-2.555.
22. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation 1993; 88: 1.999-2.009.
23. Jackson G. Coronary artery disease in women. Br Med J 1994; 309: 555-556.
24. Pagley PR, Goldberg RJ. Coronary artery disease in women: a population-based perspective. Cardiology 1995; 86: 265-269.
25. Tsuyuki RT, Teo KK, Ikuta RM, Bay KS, Greenwood PV, Montague TJ. Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Chest 1994; 105: 1.687-1.692.
26. Chaitman BR, Bourassa MG, Davis K, Rogers WJ, Tyras DH, Berger R et al. Angiographic prevalence of high-risk coronary artery disease in patients subsets (CASS). Circulation 1981; 64: 360-367.
27. Afridi I, Quiñones MA, Zoghbi WA, Cherif JB. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994; 127: 1.510-12E515.
28. Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative diagnostic value of dobutamine stress echocardiography and stress thalium-201 single-photon-emission computed tomography for detecting coronary artery disease in women. Coron Art Dis 1996; 7: 831-835.
29. Dionisopoulos PN, Collins JD, Smart SC, Knickelbine TA, Sagar KB. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr 1997; 10: 811-817.
30. Ho Y, Wu C, Huang P, Lin L, Chieng P, Chen W et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thalium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 1998; 135: 655-662.
31. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1.350-1.358.
32. Douglas PS. Is noninvasive testing for coronary artery disease accurate? Circulation 1997; 95: 299-302.
33. Hiro J, Hiro T, Reid CL, Ebrahimi R, Matsuzaki M, Gardin JM. Safety and results of dobutamine stress echocardiography in women versus men and in patients older and younger than 75 years of age. Am J Cardiol 1997; 80: 1.014-1.020.
34. Secknus MA, Marwick TH. Influence of gender on physiologic response and accuracy of dobutamine echocardiography. Am J Cardiol 1997; 80: 721-724.